Lexpos News

The Department of Health and Social Care (DHSC) has today (26/05/2023) granted the following list of price concessions for May 2023: Drug Pack size Price concession Aciclovir 800mg tablets 35 £4.60 Amiloride 5mg tablets 28 £13.15 Bisacodyl 5mg gastro-resistant tablets 60 £4.45 Buprenorphine 8mg sublingual tablets sugar free 7 £4.40 Clarithromycin 125mg/5ml oral suspension 70 £4.20 [...]

The post May 2023 Price Concessions 3rd Update appeared first on PSNC Website.

National Patient Safety Alert: Shortage of pyridostigmine 60mg tablets National Patient Safety Alert Reference Number: NatPSA/2023/006/DHSC Date issued: 24th May 2023 Brief description of the problem Pyridostigmine 60mg tablets are out of stock, resupply is expected week commencing 12 June 2023. There are three suppliers of pyridostigmine 60mg tablets: Viatris Teva Flynn Pharma The supply [...]

The post National Patient Safety Alert: Shortage of Pyridostigmine 60mg tablets appeared first on PSNC Website.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Bromfenac (Yellox® ) 900 micrograms/ml eye drops. MSN/2023/054 Tier 2 – medium impact Date of issue 25th May 2023 Bromfenac (Yellox®) 900 micrograms/ml eye drops are out of stock until w/c 3 July 2023. Ketorolac trometamol 0.5% w/v eye drops remain [...]

The post Medicine Supply Notification: Bromfenac (Yellox® ) 900 micrograms/ml eye drops appeared first on PSNC Website.

NHS England has published the template forms to be used when submitting applications and notifications for the new regulations that came into force today. Contractors are encouraged to review the updated briefing before completing a notification or application using the templates and sending to the ICB. NHS England – Pharmacy Manual – Pharmacy Template Forms. [...]

The post New PLPS regulations – template forms appeared first on PSNC Website.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 10 May 2023) has been published and includes articles on: Direct-acting oral anticoagulants (DOACs): paediatric formulations; reminder of dose adjustments in patients with renal impairment Glucose solutions: recommendations to minimise the risks associated with the accidental use of glucose solutions [...]

The post MHRA Drug Safety Update May 2023 appeared first on PSNC Website.